lead plaintiff

Gross Law Firm alerts $POET investors of June 29 deadline for securities class action over alleged tax status misrepresentation and disclosure failures.

$PSIX investors have until May 19, 2026 to join class action alleging false statements about data center sales and manufacturing costs.

Aldeyra Therapeutics faces federal securities lawsuit alleging inadequate disclosure of failed clinical trial results for reproxalap. Stock crashed 71% after FDA rejection; investor deadline May 29, 2026.

Class action lawsuit filed against Aquestive Therapeutics after company failed to disclose FDA deficiencies blocking Anaphylm approval, triggering 37% stock decline.

Class action lawsuit filed against Lufax Holding Ltd alleging securities fraud and inadequate internal controls. Lead plaintiff deadline set for May 20, 2026.

Law firm files class action against Regencell Bioscience ($RGC) alleging false statements about market manipulation risks. Investors urged to join case by June 23, 2026 deadline.

Class action lawsuit filed against $TRIP alleging false statements about regulatory risks from monopolistic practices. Lead plaintiff deadline set for May 11, 2026.

Class action lawsuit filed against Coty alleging executives made false statements about growth and profitability between November 2025 and February 2026.

Class action lawsuit filed against $ALDYA alleging false statements about reproxalap clinical trial results. Claims inconsistent data, unreliable findings.

Class action lawsuit filed against $ALIGHT alleging executives made false statements about CEO prospects, capital returns, and revenue targets. Eligible investors had securities between Nov 2024-Feb 2026.

Rosen Law Firm seeks lead plaintiffs in securities class action against Aldeyra Therapeutics over alleged reproxalap trial misstatements. Deadline: May 29, 2026.

ImmunityBio faces securities lawsuit over allegedly misleading Anktiva promotional materials. Stock fell 21% after FDA warning letter; investors can seek lead plaintiff status.

Rosen Law Firm urges $HTGC investors to join class action alleging false statements on portfolio valuations and due diligence processes.

Class action lawsuit filed against $CIGL for alleged fraudulent stock promotion involving social media misinformation and insider share dumping via offshore accounts.

Kirby McInerney LLP files securities fraud class action against $NUAI, alleging overstated Texas data center progress and fraudulent New Mexico oil/gas well scheme.

Law firm files class action against $LU for allegedly failing to disclose inadequate internal controls and misrepresenting financials between April 2023 and January 2025.

Class action lawsuit filed against $UHG alleges false statements and controlling shareholder misconduct. Investors who purchased shares between May 2025 and February 2026 can seek lead plaintiff status.

Class action lawsuit filed against $GEMI alleges false statements on crypto platform viability and overstated expansion plans. Lead plaintiff deadline set for May 18, 2026.

Class action lawsuit filed against Alight, Inc. alleging executives made false statements about CEO transition, capital returns, and revenue targets. Investors urged to act by May 15, 2026 deadline.

Class action filed against Franklin BSP Realty Trust alleges executives made false statements about dividend sustainability between November 2024 and February 2026. Lead plaintiff deadline set for April 27, 2026.